Observational studies examining the connection between pancreatitis and DPP-4 inhibitors, utilizing clinical databases from diverse countries, have produced conflicting outcomes (Chou et al., 2014; Yang et al., 2016; Pinto et al., 2018). The gene discussed is DPP4; the disease is pancreatitis.